Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth)

Duke University

Overview

The purpose of this single institution pilot study is to determine the feasibility of implementing an eHealth prostate cancer surveillance program through the eVisit electronic medical record patient portal. The investigators will assess patient compliance and satisfaction with eVisit follow up care in lieu of in person clinic visits.

Telehealth offers the opportunity to transform cancer surveillance into a patient-centered effort with shared leadership between patient and oncologist. Peer-to-peer electronic communications can improve the collaboration between oncologist and primary care provider (PCP) as patients transition back to primary care as their primary health provider. The investigators propose to test a patient-centered eHealth surveillance program utilizing novel asynchronous telehealth tools to provide patient-reported outcome symptom monitoring using the electronic medical record's patient portal (eVisit).

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Conditions

Prostate Cancer

Interventions

eVisitOTHER

electronic surveillance program in lieu of in-person clinic visit

Eligibility

Sex: MALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ≥ 18 years old with histologically confirmed prostate cancer * Completed curative intent treatment to the prostate +/- pelvis * Deemed to be "without evidence of active disease" by treating provider with at least 1 follow up visit 3 or more months after treatment completion * MyChart account or willingness to open account * Access to the internet Exclusion Criteria: * Documented extrapelvic metastases * PSA meeting definition of recurrence (\>0.2 ng/ml for prostatectomy patients or nadir + 2 ng/ml for radiation patients) and rising with doubling time less than 1 year

Locations (4)

Duke Cancer Institute Cary

Cary, North Carolina, United States

Durham Regional Hospital

Durham, North Carolina, United States

Duke University Medical Center

Durham, North Carolina, United States

Duke Raleigh Hospital

Raleigh, North Carolina, United States

Outcomes

Primary Outcomes

Proportion of patients who complete all scheduled eVisits at the end of follow-up

Defined as completion of labwork and at least 80% of the questions asked at each eVisit

Time frame: 12 months

Secondary Outcomes

Feasibility of enrollment to the eVisit program

Defined as the percentage of patients who are approached for eVisit and ultimately enroll

Time frame: 12 months

eVisit participant reported satisfaction

Reported as the summary score from validated Brief Patient Satisfaction 10-item scale instrument assessed from "1/strongly agree" through "5/strongly disagree"

Time frame: 12 months

Number of participants with cancer treatment related toxicities

Defined specifically as CTCAE Grade 2 or higher GI, GU, hormonal, and sexual toxicities

Time frame: 12 months

Number of eVisit participants with cancer recurrence

Defined as biochemical progression (PSA \>0.2 ng/ml for prostatectomy patients or nadir + 2 ng/ml for radiation patients) or metastasis (by imaging)

Time frame: 12 months

Financial impact of the eVisit program on participants compared to in person follow up clinic visits

Defined by the financial burden assessment completed by participants, scored from "0/not at all" through "4/very much"

Time frame: 12 months

Financial impact of the eVisit program on Duke University Hospital (institution) compared to in person follow up

Defined by percentage of participants/eVisits covered by insurance

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.